Integrium Cardiovascular Research

Integrium is a full-service Clinical Research Organization (CRO) specializing in the design and execution of Phase I-IV clinical trials, with a primary focus on cardiovascular, metabolic, renal, and inflammatory diseases. Founded in 1998, the company provides comprehensive drug development services, including clinical trial management, medical writing, data management, and biostatistics. Integrium is particularly recognized for its expertise in "Proof of Concept" (PoC) studies, helping small to mid-sized biotech and pharmaceutical companies validate their candidates early in the clinical cycle. The firm also maintains a significant presence in dermatology and orphan disease research, offering tailored solutions for complex trial designs.